3M CO (MMM) Current Ratio
- Current ratio · latest quarter: Value 1.24×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.24× | Current assets / current liabilities. $14.11B ÷ $11.38B ≈ 1.24× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 14.11B USD | Assets, Current |
| Current obligations | 11.38B USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Available-for-sale Securities, Current |
| Customer receivables | 3.93B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.77B USD | Inventory, Net |
| Payables | 3.11B USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.11B | $11.38B | (m) | (m) | $3.93B | $3.77B | $3.11B | (m) | 1.24× |
| 2026-03-31 | $14.39B | $9.03B | (m) | (m) | $3.75B | $3.69B | $2.79B | (m) | 1.59× |
| 2025-12-31 | $16.39B | $9.60B | (m) | (m) | $3.53B | $3.66B | $2.70B | (m) | 1.71× |
| 2025-09-30 | $16.09B | $8.73B | (m) | (m) | $3.78B | $3.89B | $2.73B | (m) | 1.84× |
| 2025-06-30 | $13.43B | $7.81B | (m) | (m) | $3.76B | $4.08B | $2.84B | (m) | 1.72× |
| 2025-03-31 | $15.66B | $9.45B | (m) | (m) | $3.50B | $3.87B | $2.76B | (m) | 1.66× |
| 2024-12-31 | $15.88B | $11.26B | (m) | (m) | $3.19B | $3.70B | $2.66B | $1.92B | 1.41× |
| 2024-09-30 | $16.30B | $11.39B | (m) | (m) | $3.53B | $4.04B | $2.69B | (m) | 1.43× |
| 2024-06-30 | $19.52B | $14.35B | (m) | (m) | $3.58B | $4.06B | $2.81B | (m) | 1.36× |
| 2024-03-31 | $21.61B | $13.16B | (m) | (m) | $4.75B | $4.90B | $3.37B | (m) | 1.64× |
| 2023-12-31 | $16.38B | $15.30B | (m) | (m) | $3.60B | $3.94B | $2.78B | $1.15B | 1.07× |
| 2023-09-30 | $16.20B | $15.47B | (m) | (m) | $4.85B | $5.07B | $3.10B | (m) | 1.05× |
| 2023-06-30 | $15.75B | $10.94B | (m) | (m) | $4.95B | $5.28B | $3.23B | (m) | 1.44× |
| 2023-03-31 | $14.96B | $10.56B | (m) | (m) | $4.64B | $5.31B | $3.13B | (m) | 1.42× |
| 2022-12-31 | $14.69B | $9.52B | (m) | (m) | $4.53B | $5.37B | $3.18B | $1.94B | 1.54× |
| 2022-09-30 | $14.89B | $9.54B | (m) | (m) | $4.72B | $5.62B | $3.06B | (m) | 1.56× |
| 2022-06-30 | $14.51B | $9.90B | (m) | (m) | $4.91B | $5.64B | $3.27B | (m) | 1.47× |
| 2022-03-31 | $14.45B | $9.15B | (m) | (m) | $4.82B | $5.29B | $3.16B | (m) | 1.58× |
| 2021-12-31 | $15.40B | $9.04B | (m) | (m) | $4.66B | $4.99B | $2.99B | $1.29B | 1.70× |
| 2021-09-30 | $16.43B | $9.63B | (m) | (m) | $4.92B | $4.95B | $2.86B | (m) | 1.70× |
| 2021-06-30 | $16.34B | $9.44B | (m) | $805.00M | $4.99B | $4.84B | $2.93B | (m) | 1.73× |
| 2021-03-31 | $15.35B | $8.36B | (m) | $501.00M | $4.82B | $4.46B | $2.67B | (m) | 1.83× |
| 2020-12-31 | $14.98B | $7.95B | (m) | (m) | $4.71B | $4.24B | $2.56B | $794.00M | 1.89× |
| 2020-09-30 | $14.11B | $7.41B | (m) | $440.00M | $4.62B | $3.98B | $2.21B | (m) | 1.90× |
| 2020-06-30 | $14.11B | $7.28B | (m) | $247.00M | $4.46B | $4.17B | $1.98B | (m) | 1.94× |
| 2020-03-31 | $15.09B | $9.13B | (m) | $224.00M | $4.82B | $4.22B | $2.21B | (m) | 1.65× |
| 2019-12-31 | $12.97B | $9.22B | (m) | $98.00M | $4.79B | $4.13B | $2.23B | (m) | 1.41× |
| 2019-09-30 | $18.02B | $7.82B | (m) | $30.00M | $5.02B | $4.01B | $2.08B | (m) | 2.30× |
| 2019-06-30 | $14.05B | $7.26B | (m) | $139.00M | $5.37B | $4.30B | $2.13B | (m) | 1.93× |
| 2019-03-31 | $14.37B | $7.13B | (m) | $539.00M | $5.17B | $4.54B | $2.31B | (m) | 2.02× |
| 2018-12-31 | $13.71B | $7.24B | (m) | $380.00M | $5.02B | $4.37B | $2.27B | (m) | 1.89× |
| 2018-09-30 | $14.42B | $7.34B | (m) | $338.00M | $5.33B | $4.44B | $2.03B | (m) | 1.97× |
| 2018-06-30 | $13.89B | $8.90B | (m) | $385.00M | $5.38B | $4.24B | $1.87B | (m) | 1.56× |
| 2018-03-31 | $14.82B | $8.96B | (m) | $604.00M | $5.25B | $4.29B | $1.87B | (m) | 1.65× |
| 2017-12-31 | $14.28B | $7.69B | (m) | $1.08B | $4.91B | $4.03B | $1.95B | (m) | 1.86× |
| 2017-09-30 | $13.66B | $6.60B | (m) | $586.00M | $5.16B | $3.98B | $1.82B | (m) | 2.07× |
| 2017-06-30 | $12.64B | $5.70B | (m) | $140.00M | $4.92B | $3.84B | $1.78B | (m) | 2.22× |
| 2017-03-31 | $11.90B | $6.00B | $2.17B | $141.00M | $4.72B | $3.61B | $1.70B | (m) | 1.99× |
| 2016-12-31 | $11.73B | $6.22B | (m) | $280.00M | $4.39B | $3.38B | $1.80B | (m) | 1.89× |
| 2016-09-30 | $12.18B | $6.40B | $2.31B | $358.00M | $4.74B | $3.61B | $1.62B | (m) | 1.90× |
| 2016-06-30 | $11.44B | $7.25B | $1.69B | $177.00M | $4.67B | $3.61B | $1.65B | (m) | 1.58× |
| 2016-03-31 | $10.87B | $7.18B | $1.34B | $176.00M | $4.49B | $3.63B | $1.58B | (m) | 1.51× |
| 2015-12-31 | $10.99B | $7.12B | $1.80B | $118.00M | $4.15B | $3.52B | $1.69B | (m) | 1.54× |
| 2015-09-30 | $11.61B | $7.03B | $1.60B | $153.00M | $4.61B | $3.71B | $1.60B | (m) | 1.65× |
| 2015-06-30 | $13.43B | $5.09B | $2.98B | $502.00M | $4.58B | $3.85B | $1.71B | (m) | 2.64× |
| 2015-03-31 | $12.52B | $5.08B | $1.79B | $1.02B | $4.41B | $3.70B | $1.80B | (m) | 2.46× |
| 2014-12-31 | $12.30B | $5.96B | $1.90B | $1.44B | $4.24B | $3.71B | $1.81B | (m) | 2.06× |
| 2014-09-30 | $12.68B | $7.71B | $1.93B | $767.00M | $4.71B | $3.94B | $1.80B | (m) | 1.65× |
| 2014-06-30 | $13.19B | $7.04B | $2.13B | $884.00M | $4.76B | $4.09B | $1.84B | (m) | 1.87× |
| 2014-03-31 | $12.76B | $7.45B | $1.95B | $860.00M | $4.60B | $3.97B | $1.87B | (m) | 1.71× |
| 2013-12-31 | $12.73B | $7.50B | $2.58B | $756.00M | $4.25B | $3.86B | $1.80B | (m) | 1.70× |
| 2013-09-30 | $13.28B | $7.44B | $2.34B | $971.00M | $4.59B | $3.95B | $1.72B | (m) | 1.79× |
| 2013-06-30 | $13.98B | $6.33B | $2.94B | $1.31B | $4.54B | $3.92B | $1.92B | (m) | 2.21× |
| 2013-03-31 | $13.86B | $5.94B | $2.93B | $1.45B | $4.42B | $3.82B | $1.82B | (m) | 2.33× |
| 2012-12-31 | $13.63B | $6.20B | $2.88B | $1.65B | $4.06B | $3.84B | $1.76B | (m) | 2.20× |
| 2012-09-30 | $14.49B | $6.59B | $3.03B | $1.99B | $4.41B | $3.84B | $1.80B | (m) | 2.20× |
| 2012-06-30 | $14.09B | $5.71B | $3.31B | $1.59B | $4.36B | $3.66B | $1.79B | (m) | 2.47× |
| 2012-03-31 | $12.85B | $5.41B | $2.33B | $1.40B | $4.32B | $3.56B | $1.78B | (m) | 2.38× |
| 2011-12-31 | $12.24B | $5.44B | $2.22B | $1.46B | $3.87B | $3.42B | $1.64B | (m) | 2.25× |
| 2011-09-30 | $13.67B | $6.17B | $3.38B | $1.49B | $4.26B | $3.60B | $1.69B | (m) | 2.22× |
| 2011-06-30 | $13.54B | $6.20B | $3.38B | $1.15B | $4.38B | $3.72B | $1.85B | (m) | 2.18× |
| 2011-03-31 | $12.64B | $5.90B | $2.75B | $1.28B | $4.21B | $3.49B | $1.81B | (m) | 2.14× |
| 2010-12-31 | $12.21B | $6.09B | $3.38B | $1.10B | $3.62B | $3.15B | $1.66B | (m) | 2.01× |
| 2010-09-30 | $14.05B | $5.39B | $4.47B | $1.39B | $3.87B | $3.21B | $1.65B | (m) | 2.60× |
| 2010-06-30 | $12.89B | $5.44B | $3.02B | $1.91B | $3.75B | $2.98B | $1.76B | (m) | 2.37× |
| 2010-03-31 | $12.11B | $5.15B | $2.85B | $1.76B | $3.57B | $2.80B | $1.58B | (m) | 2.35× |
| 2009-12-31 | $10.79B | $4.90B | $3.04B | $744.00M | $3.25B | $2.64B | $1.45B | (m) | 2.20× |
| 2009-09-30 | $11.20B | $5.77B | $3.24B | $697.00M | $3.64B | $2.63B | $1.40B | (m) | 1.94× |
| 2009-06-30 | $9.90B | $5.32B | $2.60B | $378.00M | $3.46B | $2.60B | $1.24B | (m) | 1.86× |
| 2008-12-31 | $9.60B | $5.84B | $1.85B | $373.00M | $3.19B | $3.01B | $1.30B | (m) | 1.64× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |